The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $156.89

Today's change+0.69 +0.44%
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $156.89

Today's change+0.69 +0.44%
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up (U.S.)$0.69

Thermo Fisher Scientific Inc closed up Friday by (U.S.)$0.69 or 0.44% to (U.S.)$156.89. Over the last five days, shares are unchanged, but have gained 10.60% over the last year to date. This security has outperformed the S&P 500 by 9.14% during the last year.

Key company metrics

  • Open(U.S.) $156.82
  • Previous close(U.S.) $156.20
  • High(U.S.) $157.37
  • Low(U.S.) $156.02
  • Bid / Ask-- / --
  • YTD % change+10.60%
  • Volume901,937
  • Average volume (10-day)1,120,470
  • Average volume (1-month)1,449,355
  • Average volume (3-month)1,395,340
  • 52-week range(U.S.) $117.10 to (U.S.) $158.37
  • Beta1.03
  • Trailing P/E31.52×
  • P/E 1 year forward19.30×
  • Forward PEG1.84×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.38%
  • Trailing EPS(U.S.) $4.98
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.24%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201604/02/2016Dec 31, 201512/31/2015Sep 26, 201509/26/2015Jun 27, 201506/27/2015
Revenue4,2954,6534,1234,271
Total other revenue--------
Total revenue4,2954,6534,1234,271
Gross profit1,9582,1081,8831,942
Total cost of revenue2,3372,5442,2402,329
Total operating expense3,7773,9623,5603,675
Selling / general / administrative1,1841,1801,1091,148
Research & development177180172175
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)80584024
Other operating expenses, total--------
Operating income518690563596
Interest income (expense), net non-operating-106-103-101-103
Gain (loss) on sale of assets--------
Other--------
Income before tax423583468504
Income after tax402606477512
Income tax, total21-24-9-8
Net income402603476512
Total adjustments to net income--------
Net income before extra. items402606477512
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items402606477512
Inc. avail. to common incl. extra. items402603476512
Diluted net income402603476512
Dilution adjustment--------
Diluted weighted average shares399403402402
Diluted EPS excluding extraordinary itemsvalue per share1.011.511.191.27
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.201.621.251.31